Abstract A human-mouse hybridoma clone 92-2 secreting IgM-class human monoclonal antibody to peanut allergen protein Ara h1 was established. To detect antibody-binding sequences on Ara h1, we synthesized a series of peptides of the Ara h1 protein on a multi-pin apparatus for the pin-peptide ELISA. The 92-2 human monoclonal antibody was found to recognize a sequence of GREGEQEWGTPGSHVRE ETS. Further analysis with shorter pin-peptides with eight amino acid-long showed that the sequence of QEWGTPGS was an essential linear sequence of this epitope. When the QEW part of the sequence was replaced by alanine, the 92-2 monoclonal antibody did not bind to the substituted peptide, showing that those amino acids play an important role in the binding of the 92-2 monoclonal antibody.
Introduction
The number of patients suffering from peanut allergy has been increasing, and the peanut is thought to be the sixth most common food allergen in Japan (Imamura et al. 2008; Kanagawa et al. 2009 ). Several peanut proteins have been identified as allergens by using sera from patients allergic to peanut, and Ara h1 and Ara h2 have been reported as major peanut allergens (de Jong et al. 1998; Koppelman et al. 2004; Burks et al. 1991 , Maleki et al. 2000 . We have established five clones of mouse-human hybridomas secreting IgM-class human monoclonal antibodies to peanut allergens from peripheral blood lymphocytes transformed with Epstein-Barr virus followed by cell fusion with mouse myeloma cells (Naganawa et al. 2008; Shinmoto et al. 2004) . In this paper, we present the results of a linear B-cell epitope analysis with synthesized Ara h1 oligo peptides recognized by IgM-class human monoclonal antibody 92-2.
Materials and methods
Preparation of a human-mouse hybridoma secreting anti-Ara h1 human monoclonal antibody Peripheral blood lymphocytes (PBLs) prepared from peripheral blood from a healthy donor were transformed by Epstein-Barr virus infection as described in a previous report (Naganawa et al. 2005; Shinmoto et al. 1992; Shinmoto et al. 1991) . The resulting human B-lymphoblastoid cells (BLCs) secreting IgM-class antibody to peanut allergen Ara h1 were detected by Enzyme-Linked Immunosorbent Assay (ELISA). The B-lymphoblastoid cells and mouse myeloma SP2/O3 cells were cultured with ERDF medium (Kyokuto Co. Ltd., Japan) supplemented with 10% fetal calf serum (FCS, JRH Biosciences, KA, USA). The cell suspensions of BLCs (1 9 10 7 ) and SP2/O3 cells (1 9 10 7 ) were mixed and then centrifuged. After removing supernatant, 1 ml of 50% polyethylenglycol (Hybrimax, average molecular weight of 1,450, Sigma Chemical Co., MO, USA) was added to the cell pellet. Then, the fusion mixture was diluted with 10 ml of ERDF medium and centrifuged again. The fused cells were suspended in 30 ml of ERDF medium supplemented with 15% FCS and the cells were cultured in two 96-well microculture plates for 24 h. The fused hybridoma cells were selected with O-HAT medium (ERDF medium supplemented with 10% FCS, 0.1 mmol/L hypoxanthine, 0.0003 mmol/L aminopterin, 0.016 mmol/L thymidine, and 0.002 mmol/ouabain) by replacing half of the culture medium three times a week (Shinmoto et al. 2004; Naganawa et al. 2005; Shinmoto et al. 1991) . Antibody-producing hybridomas were analyzed by ELISA. Antibody-positive cells were cloned twice and a human-mouse hybridoma clone 92-2 secreting IgM-class anti Ara h1 antibody was established.
Enzyme-linked immunosorbent assay (ELISA)
Purified peanut allergen protein Ara h1 (kindly donated by Dr. S. J. Maleki, USDA, ARS, SRRC, New Orleans, LA, USA) was diluted with 0.05 mol/L NaHCO 3 (0.2--1 micro g protein/mL), 0.06 mL of the solution was plated into ELISA plates, and the plates were kept at 4°C for 16 h. The allergen solution was discarded and the plates were then blocked with a blocking reagent (Block Ace, Dainippon Pharmaceutical Co. Ltd., Japan) for 1 h. The plates were then washed three times with phosphatebuffered saline containing 0.05% Tween-20 (PBSTween). The culture supernatants of BLCs or hybridomas (0.05 mL) were pipetted into the wells of the plates and incubated for 1 h at room temperature. The plates were washed three times with PBSTween, and 0.05 mL of anti-human IgM antibody conjugated with horseradish peroxidase (1/2,000 dilution, Biosource International, CA, USA) was added to the plates. After 1 h of incubation at room temperature, the plates were washed six times and peroxidase activity immobilized on the wells was measured by adding 0.1 mL of substrate (ABTS) solution (0.3 mg/mL 2,2 0 -azino-di-(3-ethyl benzthiazolin sulfonic acid), 0.03% H 2 O 2 in 0.1 mol/L citrate buffer, pH 4.0).
Analysis of epitopes of peanut allergen Ara h1 by the multi-pin overlapping peptide method First, we synthesized a series of overlapping peptides with 20-amino-acid length, based on an amino acid sequence of Ara h1 protein (Burks et al. 1995a; Burks et al. 1995b) as depicted in Figs. 1 and 2. The peptides were synthesized on a multi-pin apparatus (Mimotopes Pty Ltd., Clayton, Victoria, Australia) using a solid-phase method with immobilized Cterminus and acetylated N-terminus. Supernatants of hybridomas (0.1 mL) were pipetted into the wells of a 96-well micro titer plate, and multi-pin peptides were placed on the wells of the plate and reacted for 1 h at room temperature. The multi-pin peptides were washed with PBS-Tween and reacted with antihuman IgM antibody conjugated with horseradish peroxidase. After washing, enzyme activity bound to the pins was measured by adding ABTS solution in a Burks et al. (1997) and Shin et al. (1998) are underlined and an IgM epitope found in this study was shown in bold letters (aa 156-163) new 96-well plate. The absorbancy of the reaction product was measured at 405 nm. Shorter peptides and alanine-substituted peptides were also synthesized to determine the fine epitope structure.
Results and discussion
In this study, we employed an IgM class human monoclonal antibody 92-2 to evaluate an amino acid sequence of antibody binding site (B-cell epitope). At first, we synthesized a series of peptides (overlapping peptides) with 20-amino-acid length (Fig. 2) with 10-amino-acid overlapping to detect 92-2 B-cell epitope on a peanut allergen Ara h1. Of 63 peptides analyzed, binding signals were observed at pins #16, #18, #28, and #54. Control analysis without 92-2 monoclonal antibody (peroxidase conjugated second antibody only) revealed that the signals at peptide #18, #28, and #54 were non-specific binding of the second antibody (data not shown). Then we concluded that the 92-2 human monoclonal antibody to Ara h1 bound to the pin #16 with the amino acid sequence of GREGEQEWGTPGSHVREETS (aa 151-170 of Ara h1).
From the amino acid sequence of the pin #16 of 20-amino-acid peptide, we then synthesized a series of 8-amino-acid peptides (Fig. 3) . The 92-2 antibody bound only to the pin #6 with the sequence of QEWGTPGS. This QEWGTPGS sequence (aa 156-163 of Ara h1) is thought to be a ''core'' amino acid sequence of a epitope recognized with the human monoclonal antibody 92-2. Burks et al. (1997) and Shin et al. (1998) reported epitope sequences of Ara h1 detected with serum from patients allergic to peanut. Those sequences are shown in Fig. 1 (underlined) . The epitope found with the IgM class human monoclonal antibody 92-2 in this study was not involved in the epitopes detected by serum IgE from patients allergic to peanut.
To evaluate which amino acid was essential for binging of 92-2 antibody, we synthesized a series of alanine substituted peptides with 8-amino-acid length (Fig. 4) . When the first amino acids Q (glutamine) was replaced with alanine (peptide #2), the 92-2 antibody completely lost its binding activity to the peptides. Also the 92-2 antibody did not bind to the peptides when the second and the third amino acids of E (glutamic acid) and W (tryptophane) were replaced with alanine (peptides #3 and #4). This means that those Q (glutamine), E (glutamic acid), and W (tryptophane) amino acid residues played very important roles in antibody binding of the 92-2 antibody.
In a type I allergic reaction, IgE-class antibodies play a key role on the mast-cell surface (Ishizaka and Ishizaka 1978; Prussin and Metcalfe 2006; Miescher and Vogel 2002) . When the allergens bind to IgE antibodies on the mast cells, the mast cells release chemical mediators such as histamine and other chemical mediators, which induce allergic symptoms. Contrary to this, the human monoclonal antibodies obtained in our previous study were all of the IgM class (Shinmoto et al. 2004) . This seems to be due to the fact that the population of cells transformed by the Epstein-Barr virus infection were B-cells expressing IgM antibodies on the cell surface (Crain et al. 1989; Zhu et al. 2008) . IgM antibodies on the B-cell surface were thought to play the role of antigen receptors (O'Neill et al. 2005) . B-cells also act as antigen-presenting cells (APC). When certain antigens bind to IgM antibody on B-cells, the B-cells incorporate the antigen molecule and process the antigen by proteolytic digestion. The processed antigen peptides are then presented on a class II major histocompatible complex (MHC) molecule on the cell surface. The complex of the antigen peptide and class II MHC is recognized by a T-cell receptor on T-cell surface, and the T-cell secretes specific cytokines such as IL4 and IL13 to induce the B cell to an IgE-secreting plasma cell (Vries et al. 1993; Hajoui et al. 2004; Kajiwara et al. 2004 ). The IgM antibody on the B cell may play a very important role in the Ig-class switch from IgM to IgE. Our finding of B-cell epitope with IgM-class human monoclonal antibody to Ara h1 in this study may contribute to further analysis of antigen presentation of Ara h1 by B-cells to helper T cells.
Conclusion
In this study, we demonstrated an antibody-binding amino-acid sequence (B-cell epitope) of the peanut allergen Ara h1 by using human IgM-class monoclonal antibody 92-2. The 92-2 antibody recognized a peptide sequence of QEWGTDGS, and the aminoacid sequence of Q, E, and W played an essential role in the binding of the 92-2 antibody. This human IgMclass monoclonal antibody seems to be useful for analyzing APC-T-cell interaction in vitro. 
